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The large subunit of herpes simplex virus type 2 (HSV-2) ribonucleotide reductase (ICP10) was identified in sucrose
gradient-purified HSV-2 virions by immunoprecipitation/immunoblotting with antibody specific for the protein kinase (PK)
domain. Immunoblotting of individual gradient fractions indicated that ICP10 cosediments with the major capsid protein and
the highest virus titers. ICP10 was not labeled by iodination of purified virions, indicating that it is not located on the virion
surface. After envelope glycoproteins were removed by detergent treatment, ICP10 was associated with capsid-tegument
particles and became sensitive to trypsin digestion. The capsid-tegument-associated ICP10 was phosphorylated and had
PK activity in vitro and on Immobilon membranes. A mutant ICP10 protein deleted in the PK domain (p95) was also associated
with purified virions (ICP10DPK virus) but it lacked PK activity. The data indicate that ICP10 is contained within the tegument
component where it retains intrinsic PK activity. q 1997 Academic Press
INTRODUCTION binding sites differs for ICP10 and ICP6 PK, and the two
PKs have different ionic and ATP requirements (Peng et
Herpes simplex virus (HSV) encodes its own ribonucle- al., 1996). Thus, ICP10 PK has two ATP binding sites that
otide reductase (RR). Like the mammalian and bacterial are located within the PK domain (Nelson et al., 1996).
enzymes, the viral RR consists of the large 140-kDa (RR1) The ATP binding site of ICP6 PK is outside of the PK
and small 38-kDa (RR2) subunits (Cohen, 1972; Dutia, domain (Cooper et al., 1995).
1983; Huszar et al., 1983; Bacchetti et al., 1984; Preston In constitutively expressing cells, ICP10 PK is involved
et al., 1984; Frame et al., 1985; Ingemarson and Lankinen, in the activation of the ras signaling pathway causing
1987). RR1, designated ICP6 for HSV-1 and ICP10 for increased cell proliferation and anchorage-independent
HSV-2, has a bipartite regulation which includes an im- growth (Jariwalla et al., 1980; Hayashi et al., 1985; Ali et
mediate early (IE) component. Thus, RR1 is first ex- al., 1991; Smith et al., 1994; Hunter et al., 1995). However,
pressed at 2 hr postinfection (p.i.) and in the absence of the role of RR1 PK in virus growth is still poorly under-
de novo protein synthesis. Its expression is independent stood. It has been suggested that the IE regulation of
of the major regulatory protein ICP4 but it is activated by RR1 expression is required for the function of its PK
the interaction of the virion tegument protein VP16 (also domain (Wymer et al., 1989; 1992; Desai et al., 1993). Our
designated Vmw65 or a-TIF) with the oct-1 cellular tran- recent studies using a HSV-2 mutant deleted in the PK
scription factor at the octamer/TAATGAARAT sequence domain of ICP10 (Peng et al., 1996) indicated that the PK
in the RR1 promoter (Wymer et al., 1989, 1992; Desai et activity is required for expression of selected IE proteins
al., 1993). (Smith et al., submitted), implying that ICP10 must be
Unlike RR1 subunits in eukaryotic, prokaryotic, and present in infected cells before IE gene expression. In-
other herpesvirus enzymes, the HSV RR1 contains a deed, previous studies had shown that RR1 is associated
unique amino-terminal region which has poor homology with purified virions (Ali, 1995). However, it is still unclear
among the two HSV types and has been assigned serine/ whether the virion-associated ICP10 has PK activity, and
threonine protein kinase (PK) activity (Chung et al., 1989, the location of ICP10 within the virion is unknown. The
1990; Ali et al., 1991; Luo et al., 1991; Paradis et al., studies presented in this report were designed to ad-
1991; Conner et al., 1992). Insertional and site-directed dress these questions.
mutagenesis studies demonstrated that the RR1 PK activ-
ity is intrinsic (Luo and Aurelian, 1992; Cooper et al., MATERIALS AND METHODS
1995; Nelson et al., 1996), but the location of the ATP
Cells and virus
Human epidermoid carcinoma No. 2 (Hep-2) cells were1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (410) 706-2513. E-mail: laurelia@umabnet.ab.umd.edu. obtained from American Type culture collection and
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grown in Hank’s Medium 199 with 10% calf serum. HSV- volume were incubated with 1 mg lactoperoxidase (Sigma
Chemicals, St. Louis, MI) and 1 mCi [125I] at room temper-2 (strain G) was grown and titrated (by plaque assay) as
described (Aurelian et al., 1989). The construction of the ature. At 5-min intervals for 15 min, 2 ml of H2O2 were
added with constant stirring, and the reaction wasHSV-2 mutant deleted in the ICP10 PK domain
(ICP10DPK) which expresses a PK-negative 95-kDa pro- stopped by the addition of 5 mM potassium iodide and
0.5 mM Na2S205 . To remove free iodine, virions weretein (p95) was previously described (Peng et al., 1996).
pelleted by centrifugation at 25,000 g (2 hr; 47).
Antibodies
Immunoblotting assay
The production and specificity of the anti-LA-1 anti-
body specific for ICP10 amino acids 13–26 were pre- Purified virion preparations were subjected to SDS–
PAGE on 8.5% polyacrylamide gels. Proteins were elec-viously described (Aurelian et al., 1989). Monoclonal anti-
body (MAb) 56S, specific for the major capsid protein trotransferred onto nitrocellulose membranes as pre-
viously described (Aurelian et al., 1989) and immunoblot-ICP5, was obtained from Dr. Martin Zweig. MAb II188-4
specific for gC was obtained from Dr. P. Spear (North- ting was performed by incubation (1 hr at room tempera-
ture) with the respective antibodies followed by proteinwestern U. Chicago, IL).
A–peroxidase (Sigma). Detection was with ECL detec-
Metabolic labeling and virion purification tion reagents (Amersham, Chicago, IL) as described
(Smith et al., 1994).
Hep-2 cells were infected with HSV-2 (m.o.i. of 5). At
4 hr p.i. they were labeled with [35S]methionine (10 mCi/ Protein kinase assay
ml, sp act 1120 Ci/mmol, Dupont, NEN Research Prod-
ucts, Boston, MA) or [32P]orthophosphate (50 mCi/ml, Du- PK activity was assayed as previously described
pont, NEN Research Products) in EMEM without methio- (Chung et al., 1989; Smith et al., 1992, 1994; Peng et
nine or EMEM without phosphate, respectively. Media al., 1996). Briefly, virions purified by sucrose gradient
were supplemented with 1% dialyzed FCS. At 24 hr p.i., centrifugation were treated with detergent as described
when the CPE was complete, the culture medium was above and the resulting soluble (envelope) and insoluble
cleared of cell debris by centrifugation (1,000 g; 30 min (capsid-tegument) fractions were resuspended in kinase
at 47) and the virions were pelleted from the supernatant reaction buffer consisting of 20 mM Tris–HCl (pH 7.4), 5
(25,000 g; 2 hr at 47) and resuspended in 10 mM Tris, mM MgCl2 , 2 mM MnCl2 , and 10 mCi of [g-
32P]ATP (3000
pH 7.4, 100 mM NaCl, 1 mM EDTA. The virus suspension Ci/mmol, Dupont, New England Nuclear Research Prod-
was layered onto a 12-ml linear sucrose gradient (20– ucts), and incubated at 307 for 15 min. Reaction mixtures
60% wt/vol) and centrifuged at 50,000 g for 20 hr. The were solubilized in gel denaturing buffer and subjected
virus band was collected by puncturing the side of the to electrophoresis on SDS–polyacrylamide gels as pre-
tube with a needle and syringe. Individual fractions (1 viously described (Smith et al., 1992, 1994).
ml) were collected from the bottom of the tube. Labeled Assay of ICP10 PK activity following transfer of virion
virions were analyzed by SDS–PAGE on 8.5% acrylamide proteins to Immobilon membranes was as described by
gels and visualized by autoradiograhy (Chung et al., 1989; Luo and Aurelian (1992). Briefly, proteins in the unlabeled
Smith et al., 1992, 1994). Quantitation was by densitomet- soluble (envelope) and insoluble (capsid-tegument) frac-
ric scanning using the Image Quant densitometer. tions were separated by SDS–PAGE on 8.5% polyacryl-
amide gels and transferred onto Immobilon P mem-
Detergent treatment of purified virions branes (Millipore, 0.45-mm pore size). Blots were incu-
bated for 1 hr at room temperature with gentle rocking
Virions purified by sucrose gradient centrifugation
in 7 mM guanidine HCl (Sigma, grade I), 50 mM Tris, 50
were pelleted by centrifugation at 25,000 g (2 hr; 47). They
mM dithiothreitol, and 2 mM EDTA (pH 8.0). The proteins
were resuspended in 0.01 M Tris–HCl, pH 7.4, 0.15 M
were renatured in 100 mM NaCl, 50 mM Tris–HCl, pH
NaCl, 1% Triton X-100, and incubated on ice for 30 min.
7.5, 2 mM dithiothreitol, 2 mM EDTA, 1% bovine serum
Soluble (envelope) and insoluble (capsid-tegument) frac-
albumin (BSA, Sigma), and 0.1% Triton X-100 for 18 hr at
tions were separated by centrifugation at 114,000 g for
47, and blots were blocked with 5% BSA in 50 mM Tris–
2 hr at 47.
HCl, pH 7.4, 150 mM NaCl, for 1 hr at room temperature.
PK activity was assayed by incubation of the blots in 50Iodination of purified virions
mM Tris–HCl, pH 7.4, 10 mM MgCl2 , 2 mM MnCl2 , and
50 mCi/ml [g-32P]ATP (3000 Ci/mmol) for 30 min at roomUnlabeled virions from the sucrose gradient fraction
that had the highest virus titer were pelleted by centrifu- temperature. The reaction was terminated by washing
twice with 50 mM Tris–HCl (pH 7.5), once with 50 mMgation (25,000 g; 2 hr; 47), resuspended in 0.01 M Tris –
HCl, pH 7.4, and labeled with [125I], as described (Mor- Tris–HCl (pH 7.5), and 0.05% Triton X-100, and once with
50 mM Tris–HCl (pH 7.5). The washed blots were treatedrison et al., 1974). Briefly, virions in a 100-ml reaction
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ICP10 amino acids 13–26 (Fig. 1B), suggesting that
ICP10 may be associated with purified virions.
To confirm that ICP10 is virion-associated, unlabeled
extracellular virions were centrifuged on a 20–60% linear
sucrose gradient and the location of ICP10 in individual
fractions was compared to that of: (i) the major capsid
protein VP5, as determined by immunoblotting with the
respective antibodies, and (ii) infectious virus titers, as
determined by plaque assays. ICP10 colocalized with
VP5 and infectious virus, with fraction 4 containing the
largest quantities of both proteins and the highest virus
titers (Fig. 1C). The number of ICP10 molecules per virion
was estimated according to a method described by
Heine et al. (1974) from the autoradiograph of the [35S]-
methionine labeled proteins in the purified virions as
quantitated by densitometric scanning. There are approx-
imately 141 ICP10 molecules per virion, and this is in the
range previously described for the virion-associated ICP4
and ICP0 (Yao and Courtney, 1989, 1992).
ICP10 is contained within the tegument region
Two series of experiments were done in order to deter-
mine the location of ICP10 in the purified virions. In the
first series, virions from the sucrose gradient fractionsFIG. 1. Extracellular virions from HSV-2-infected Hep-2 cells labeled
that had the highest titers of infectious virus (Fig. 1C,with [35S]methionine (4–24 hr p.i.) were purified by centrifugation on
fractions 3–5) were labeled with [125I] as described under20 –60% linear sucrose gradients and the virus band was collected
from the side of the tube. Virion proteins were resolved by SDS–PAGE Materials and Methods and the proteins were resolved
(8.5% acrylamide) and analyzed by autoradiography (A) or transferred to by SDS–PAGE. As previously described (Skulstad et al.,
nitrocellulose membranes and immunoblotted with anti-LA-1 antibody
1995), major iodinated proteins were 120, 115, 84, andspecific for ICP10 amino acids 13–26 (B). Individual fractions from
50 kDa, which is respectively consistent with glycopro-sucrose gradients of unlabled extracellular virions were resolved by
teins gB, gH, gC/gE, and gD (Fig. 2, lane 2). Two relativelySDS –PAGE (8.5% acrylamide), transferred to nitrocellulose mem-
branes, and immunoblotted with anti LA-1 antibody (specific for ICP10) minor iodinated proteins were 65 and 82 kDa (Fig. 2,
or MAb 56S (specific for VP-5) (C). Virus titers in aliquots from each lane 2). They probably represent tegument proteins VP16
fraction are expressed as PFU 1 106/ml.
and UL47 (VP13/14), which were rendered accessible
to iodination by envelope breakdown during purification
(Skulstad et al., 1995). ICP10 was not iodinated, sug-with 1 M NaOH at room temperature for 10 min to reduce
gesting that it is not on the virion surface or its proximitybackground and exposed to X-Omat film for autoradiog-
and is, therefore, unaccessible to iodination even if theraphy.
envelope undergoes partial breakdown during virus puri-
fication.
RESULTS The second series of experiments examined the fate
of ICP10 when the virion envelope is solubilized withICP10 is associated with purified virions
nonionic detergents. Purified virions were treated with
1% Triton X-100 and subjected to high speed centrifuga-Extracellular virions were purified from the medium of
HSV-2-infected cells labeled with [35S]methionine from 4 tion. The pelleted (insoluble) fraction containing the cap-
sid and tegument components (P) and the supernatantto 24 hr p.i., by centrifugation on 20–60% linear sucrose
gradients as described under Materials and Methods. fraction (S) containing the solubilized envelope proteins
were analyzed by SDS–PAGE and immunoblotting withProteins in the virion containing band (collected from the
side of the tube) were separated by SDS–PAGE on 8.5% antibodies to ICP10, VP5, and glycoprotein gC. As shown
in Fig. 3C, 80–90% of gC was solubilized from virus parti-polyacrylamide gels and analyzed by autoradiography.
The protein profile (Fig. 1A) was similar to those pre- cles by detergent treatment and released into the super-
natant fraction. By contrast, 90% of ICP10 (Fig. 3B) andviously reported for HSV-2 (Strnad and Aurelian, 1976;
Cassai et al., 1975) and contained a 140-kDa protein 100% of VP5 (Fig. 3A) were in the pelleted particles which
contain the capsid-tegument structures. Because ICP10which is consistent with ICP10. The 140-kDa protein was
recognized by anti-LA-1 antibody which is specific for was not seen in purified nucleocapsids (data not shown),
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the data suggest that most of the ICP10 protein is associ-
ated with the tegument fraction. Approximately 10% of
the total ICP10 protein was also seen in the soluble
fraction (Fig. 3B), suggesting that small amounts can be
solubilized with detergent treatment. This could be due
to the presence of small amounts of ICP10 in the virion
envelope, albeit not on its surface, or it could reflect
the tightness of the ICP10 association with the capsid
particles.
Inasmuch as most of the virion-associated ICP10 can-
not be solubilized by detergent treatment, and it is not
located on the virion surface, ICP10 should be resistant
to trypsin treatment of the virions. To examine the validity
FIG. 3. Unlabeled extracellular HSV-2 virions were purified by centrif-of this interpretation purified virions were treated (15 min,
ugation on 20–60% linear sucrose gradients, treated with 1% Triton X-377) with trypsin (0.1 mg/ml) in the presence or absence
100, and pelleted by high speed centrifugation (114,000 g). Proteinsof Triton X-100, as described by Yao and Courtney (1989,
from the pelleted capsid-tegument fraction (P) and the solubilized enve-
1992). The reaction was terminated by the addition of lope fraction (S) were resolved by SDS–PAGE (8.5% acrylamide), trans-
soybean trypsin inhibitor (0.5 mg/ml) and 0.4 mM phenyl- ferred to nitrocellulose, and immunoblotted with VP5-specific MAb 56S
(A), ICP10-specific anti-LA-1 antibody (B), or gC-specific MAb (C). Puri-methylsulfonyl fluoride. The proteins were acetone pre-
fied virions were treated with 0.1 mg/ml of trypsin in the absence (T)cipitated, resolved by SDS–PAGE, and immunoblotted
or presence (TD) of 1% Triton X-100 for 15 min at 377. The reactionwith anti-LA-1 antibody. The data in Fig. 3D indicate that
was terminated by the addition of 0.5 mg/ml of soybean trypsin inhibitor
ICP10 is sensitive to trypsin treatment only in the pres- and 0.4 mM phenylmethyl-sulfonyl fluoride followed by acetone precipi-
ence of detergent, suggesting that the virus envelope tation. Proteins were resolved by SDS–PAGE (8.5% acrylamide) and
immunoblotted with anti LA-1 antibody (D).protects ICP10 from trypsin digestion.
The virion associated ICP10 is phosphorylated and
has PK activity and has PK activity. In a first series of experiments, cells
were infected with HSV-2, labeled with [35S]methionineThese experiments were designed to determine
or [32P]orthophosphate from 4 to 24 hr p.i., and the extra-whether the virion-associated ICP10 is phosphorylated
cellular virions were purified by centrifugation on 20–
60% linear sucrose gradients. Virions from fraction 4
which had maximal virus titers (Fig. 1C) were analyzed by
SDS–PAGE as described under Materials and Methods.
Nine proteins (212, 140, 120, 92, 82, 61, 58, 54, and 32
kDa), respectively, consistent with the size of VP1/2,
ICP10, UL37, VP11/12, VP13/14, VP16, vhs, UL13, and
VP22 were resolved in the [32P]-labeled virions (Fig. 4A,
lane 2). Immunoblotting of the [32P]-labeled virions with
anti LA-1 antibody confirmed that the 140-kDa phospho-
protein is ICP10 (Fig. 4A, lane 3).
To determine whether the virion-associated ICP10 has
PK activity, unlabeled purified virions were treated with
1% Triton X-100 and capsid-tegument particles (P) were
separated from solubilized envelope proteins (S) by cen-
trifugation. The fractions were assayed for PK activity as
described under Materials and Methods. Phosphorylated
ICP10 was observed primarily in the capsid-tegument
fraction (Fig. 4B). A minor phosphorylated band was also
seen in the soluble fraction, but its levels were approxi-
mately one-tenth of those in the capsid-tegument. The
ratio of phosphorylated ICP10 in the capsid-tegument/FIG. 2. Unlabeled extracellular virions from HSV-2-infected Hep-2
cells were purified by centrifugation on 20–60% linear sucrose gradi- soluble (P/S) fractions was 10:1, which is virtually identi-
ents. Virions from fractions 3– 5 were labeled with [125I] in a reaction cal to that seen by immunoblotting (Fig. 3B). VP5 and gC
containing lactoperoxidase and hydrogen peroxide. Proteins were re-
were not phosphorylated. These data indicate that thesolved by SDS–PAGE (8.5% acrylamide gels) and visualized by autora-
virion-associated ICP10 is phosphorylated in vitro, butdiography (lane 2). [35S]Methionine-labeled virions purified in parallel
are shown in lane 1. they do not demonstrate that phosphorylation is medi-
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ated by ICP10 PK. To address this question, capsid-tegu-
ment (P) and soluble (S) fractions from purified virions
were resolved by SDS–PAGE, transferred to Immobilon
membrane, and the blot was used in PK assay, as pre-
viously described (Luo and Aurelian, 1992). A 140-kDa
phosphorylated protein, consistent with ICP10, was ob-
served in the capsid-tegument fraction (Fig. 4C), sug-
gesting that the virion-associated ICP10 has PK activity.
Although low levels of ICP10 were seen in the soluble
fraction from detergent-treated virions (Fig. 3B), a phos-
FIG. 5. Extracellular virions from ICP10DPK-infected cells were puri-
fied by centrifugation on 20–60% linear sucrose gradients and the virus
band was collected from the side of the tube. Virion proteins were
resolved by SDS–PAGE (8.5% acrylamide), transferred to nitrocellulose
membranes, and immunoblotted with anti-LA-1 antibody specific for
ICP10 amino acids 13–26 (C) or preimmune serum (D). Similarly frac-
tionated extracellular [35S]labeled (A) and immunoblotted with anti-LA-
1 antibody (B), HSV-2 virions served as control. Purified ICP10DPK
virions were treated with detergent and capsid-tegument particles (E)
and detergent-solubilized envelope proteins (F) were assayed for in
vitro PK activity and the proteins were resolved by SDS–PAGE (8.5%
gels) and visualized by autoradiography.
phorylated species was not seen on blots containing the
soluble fraction (Fig. 4C). Presumably, this reflects the
low quantities of ICP10 in this fraction and the relative
insensitivity of the assay (Luo and Aurelian, 1992).
The PK deleted ICP10 protein p95 is virion associated
Because ICP10 is associated with the virion tegu-
ment, we considered the possibility that its PK domain
is required for association. To examine the validity of
such an interpretation, extracellular virions were puri-
FIG. 4. (A) Extracellular virions from Hep-2 cells infected with HSV- fied by sucrose gradient centrifugation from the medium
2 and labeled with [32P]orthophosphate (4–24 hr p.i.) were purified of cells infected with ICP10DPK virus, a mutant deleted
by centrifugation on 20–60% linear sucrose gradients. Proteins were
in ICP10 PK (Peng et al., 1996), and the proteins sepa-resolved by SDS–PAGE (8.5% acrylamide) and analyzed by autoradiog-
rated by SDS – PAGE (on 8.5% polyacrylamide gels) andraphy (lane 2) or transferred to nitrocellulose and immunoblotted with
anti LA-1 (lane 3). [35S]Methionine-labeled virions purified in parallel transferred to nitrocellulose membranes were immu-
are shown in lane 1. (B) Purified virions untreated with detergent (V), noblotted with anti-LA-1 antibody. Extracellular HSV-2
capsid-tegument particles (P), and detergent-solubilized envelope pro- virions were studied in parallel. A 95-kDa protein consis-
teins (S) were assayed for in vitro PK activity and the proteins were
tent with the PK-deleted ICP10 protein p95 (Luo andresolved by SDS–PAGE (8.5% gels) and visualized by autoradiography.
Aurelian, 1992; Peng et al., 1996) was recognized by(C) Extracellular virus (1011 PFU) was purified by sucrose gradient cen-
trifugation and treated with detergent and capsid-tegument (P) and anti-LA-1 antibody in ICP10DPK virons (Fig. 5C). The
solubilized envelope (S) fractions obtained as described above. Pro- 140-kDa ICP10 protein was recognized by the anti-LA-
teins in the two fractions were separated by SDS–PAGE (8.5% acryl- 1 antibody in HSV-2 virions (Fig. 5B) and preimmune
amide), transferred to Immobilon membranes, and renatured. The re-
serum was negative (Fig. 5D).gion of the membrane containing ICP10 was assayed for PK activity,
To examine whether p95 was phosphorylated, purifiedby incubation with a PK reaction mixture containing [g-32P]ATP,
washed, and autoradiographed, as described (Luo and Aurelian, 1992). ICP10DPK virions were treated with 1% Triton X-100,
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capsid-tegument particles (P) were separated from solu- HSV-2 for 6–9 hr (Strnad and Aurelian, 1978), when virus
progeny production reaches maximal levels, supportsbilized envelope proteins (S) by centrifugation, and the
fractions were assayed for PK activity as described under such an interpretation. The low levels of ICP10 in the
soluble fraction from detergent-treated virions may repre-Materials and Methods. Phosphorylated p95 was not ob-
served in either fraction (Figs. 5E and 5F), suggesting sent envelope-associated ICP10, which escapes detec-
tion by the relatively insensitive iodination procedure orthat the PK negative p95 is associated with purified viri-
ons and indicating that the PK domain is not required for low levels of ICP10 released from the tegument during
treatment with detergent. Present findings do not differ-ICP10 association with the virion tegument.
entiate between these two interpretations.
The virion-associated ICP10 is phosphorylated andDISCUSSION
has PK activity in vitro. We conclude that ICP10 is auto-
phosphorylated because: (i) PK activity was still observedThe salient features of these studies are the finding
of detectable amounts of ICP10 associated with purified when the assay was done on an immobilon membrane,
conditions which exclude the contribution of other viral orvirions, most likely within the tegument structure, and
the observation that the virion-associated ICP10 has PK cellular proteins, and (ii) p95 is associated with purified
ICP10DPK virions, but it is not phosphorylated. Becauseactivity. The following comments seem pertinent with re-
spect to these findings. ICP10 is primarily located in the tegument, PK activity
was observed only after the virions were treated withThe presence of a 140-kDa protein in purified virions
was first described in the 70s (Cassai et al., 1975; Strnad Triton X-100, thereby presumably explaining the failure
of Ali (1995) to detect ICP10 PK activity in purified virions.and Aurelian, 1976), and it probably represents RR1 (Ali,
1995). Indeed, we found that [35S]methionine labeled However, the role of ICP10 PK in the phosphorylation of
other virion proteins is still unresolved. Previous in vitroICP10 colocalizes with infectivity on sucrose gradients.
Also, upon Ficol gradient centrifugation, which is known studies attributed the phosphorylation of virion proteins
to UL13 (Lemaster and Roizman, 1980), and, at least, oneto separate H from L particles (Szilagyi and Cunningham,
1991), we found that ICP10 localizes with H, but not L other PK (US3) was also associated with virions (Zhang
et al., 1990). To the extent of our knowledge, RR1 is theparticles (data not shown), as also reported by Ali (1995).
We used several approaches to demonstrate that ICP10 only viral PK the intrinsic activity of which was demon-
strated by rigorous genetic and biochemical criteria (Luois within the tegument. Iodination was used to identify
proteins located on the virion surface. As previously re- and Aurelian, 1992; Cooper et al., 1995; Nelson et al.,
1996; Peng et al., 1996). While consensus is lacking forported for HSV-1 (Skulstad et al., 1995), there were four
major iodinated species, respectively consistent with gly- the transphosphorylating activity of ICP6 (Chung et al.,
1989; Paradis et al., 1991; Conner et al., 1992; Ali et al.,coproteins gB, gH, gC/gE, and gD, and two relatively
minor species which are consistent with tegument pro- 1991; Peng et al., 1996), this appears to reflect the use
of different constructs and experimental conditions (Pengteins VP16 and UL47. The latter presumably reflect partial
envelope breakdown during purification (Skulstad et al., et al., 1996). However, the role of ICP10 PK in the phos-
phorylation of other virion proteins is unclear, and we1995). However, ICP10 was not iodinated, suggesting
that it is not located on the virion surface, nor in sufficient do not exclude the possibility that virion proteins are
differentially phosphorylated by various virion-associatedproximity to the surface to be accessible to iodination
under conditions of partial envelope breakdown. PKs. Also, phosphorylation may differ in infected cells,
as compared to in vitro assays.The following evidence supports the conclusion that
ICP10 is located in the tegument region. First, when puri- The finding that ICP10, a functional protein, is present
in the virion tegument is consistent with previous reportsfied virions were treated with Triton X-100, which solubi-
lizes the envelope proteins, only a small proportion (ap- which suggest that approximately one half of the HSV
structural proteins are contained within the tegumentproximately 10%) of the total virion-associated ICP10 pro-
tein was in the soluble fraction which contained structure and many of them are functional proteins. Func-
tional proteins located in the tegument include the IEglycoprotein C. Most of the ICP10 protein cosedimented
with the major capsid protein VP5, although it is not regulatory proteins ICP0 and ICP4 (Yao and Courtney,
1989, 1992), UL36 (VP1/2) which is associated with theassociated with capsids isolated from infected cells nu-
clei (Strnad and Aurelian, 1978). Second, the virion-asso- release of viral DNA from the capsids (an IE function)
and the cleavage and packaging of viral DNA (a lateciated ICP10 was not trypsin sensitive until the purified
virions were disrupted by detergent treatment, sug- function) (Batterson et al., 1983; Batterson and Roizman,
1983; Chou and Roizman, 1989; McNabb and Courtney,gesting that the virion envelope protects ICP10 from tryp-
sin digestion. It is possible that ICP10 is incorporated 1992), UL41, (vhs) responsible for decreased mRNA sta-
bility and inhibition of host cell translation (Smibert et al.,into the tegument when the nucleocapsids bud from the
inner nuclear membrane. The finding that ICP10 is pri- 1992; Kwong et al., 1988), UL48 (Vmw65, VP16, or a-
TIF) the protein responsible for the trans-activation of IEmarily in the perinuclear region of cells infected with
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Batterson, W., Furlong, D., and Roizman, B. (1983). Molecular geneticsgenes (Ace et al., 1988; Weinheimer et al., 1992; Bat-
of herpes simplex virus. VII. Further characterization of a ts mutantterson and Roizman, 1983; Batterson et al., 1983; Camp-
defective in release of viral DNA and in other stages of viral reproduc-
bell et al., 1984; Pellet et al., 1985) and UL13 which is tive cycle. J. Virol. 45, 397–407.
presumed to have PK activity (Overton et al., 1992). Batterson, W., and Roizman, B. (1983). Characterization of the herpes
An important question is the function of the virion- simplex virion-associated factor responsible for the induction of a
genes. J. Virol. 46, 371–377.associated ICP10. ICP10 could be inadvertently incorpo-
Campbell, M. E. M., Palfreyman, J. W., and Preston, C. M. (1984). Identifi-rated into the virion particle, or it could be a minor struc-
cation of the herpes simplex virus DNA sequence which encodes atural component of the virion tegument region that also
trans-activating polypeptide responsible for the stimulation of the
functions in the virus replicative cycle, such as VP16 (Ace immediate early transcription. J. Mol. Biol. 180, 1–19.
et al., 1988; 1989; Batterson and Roizman, 1983). We do Cassai, E. N., Sarmiento, M., and Spear, P. G. (1975). Comparison of
the virion proteins specified by herpes simplex virus types 1 and 2.not believe that RR1 is required for the integrity of the
J. Virol. 16, 1327–1331.tegument because RR1-deleted HSV-2 (unpublished) and
Chou, J., and Roizman, B. (1989). Characterization of DNA sequenceHSV-1 (Goldstein and Weller, 1988) mutants have a virion
common and DNA sequence specific proteins binding to the cis-
structure similar to that of the wild-type virus. The PK acting sites for the cleavage of the terminal a sequence of herpes
domain is not required for ICP10 incorporation into viri- simplex virus 1 genome. J. Virol. 63, 1059–1068.
ons, as indicated by the presence of p95 in purified Chung, T. D., Wymer, J. P., Smith, C. C., Kulka, M., and Aurelian, L.
(1989). Protein kinase activity associated with the large subunit ofICP10DPK virions. By contrast, it is possible that the
the herpes simplex virus type 2 ribonucleotide reductase (ICP10). J.virion-associated ICP10 PK functions alone, or synergisti-
Virol. 63, 3389–3398.cally with ICP0, ICP4, and/or VP16, to activate expression
Chung, T. D. , Wymer, J. P., Kulka, M., Smith, C. C., and Aurelian, L.
of IE genes at the initial stage of the virus reproductive (1990). Myristylation and polylysine-mediated activation of the protein
cycle. Given earlier findings (Batterson et al., 1983) that kinase domain of the large subunit of herpes simplex virus type 2
ribonucleotide reductase (ICP10). Virology 179, 168–178.there exists virion-associated factor(s) that induce ex-
Cohen, G. H. (1972). Ribonucleotide reductase activity of synchronizedpression of the chimera ICP4 promoter-thymidine kinase
KB cells infected with herpes simplex virus. J. Virol. 9, 408–418.gene, it may be reasonable to speculate that the virion-
Conner, J., Cooper, J., Furlong, J., and Clements, J. B. (1992). An autopho-
associated ICP10 PK represents a factor that can induce sphorylating but not transphosphorylating activity is associated with
IE gene expression at the initial stages of virus infection. the unique N terminus of the herpes simplex virus type 1 ribonucleo-
tide reductase large subunit. J. Virol. 66, 7511–7516.Indeed: (i) the virion-associated ICP10 retains PK activity
Cooper, J., Conner, J., and Clements, J. B. (1995). Characterization ofwhich is absent from the virion-associated p95 which is
the novel protein kinase activity present in the R1 subunit of herpesdeleted in the PK domain, and (ii) basal expression from
simplex virus ribonucleotide reductase. J. Virol. 69, 4979–4985.the ICP10 promoter is independent of other viral proteins
Desai, P., Ramakrishnan, R., Lin, Z. W., Osak, B., Gliorioso, J. C., and
(Wymer et al., 1989, 1992; Zhu and Aurelian, 1997). Our Levine, M. (1993). The RR1 gene of herpes simplex virus type 1 is
recent finding that ICP10DPK virus fails to express ICP4 uniquely trans activated by ICP0 during infection. J. Virol. 67, 6125–
6135.and ICP27 (Smith et al., submitted), supports this inter-
Dutia, B. M. (1983). Ribonucleotide reductase induced by herpes sim-pretation.
plex virus has a virus specified constituent. J. Gen. Virol. 64, 513–
521.REFERENCES
Frame, M. C., Marsden, H. S., and Dutia, B. M. (1985). The ribonucleo-
Ace, C. I., Dalrymple, M. A., Ransay, F. H., Preston, V. G., and Preston,
tide reductase induced by herpes simplex virus type 1 involves mini-
C. M. (1988). Mutational analysis of the herpes simplex virus type 1
mally a complex of two polypeptides (136K and 38K). J. Gen. Virol.
trans-inducing factor Vmw65. J. Gen. Virol. 69, 2595–2605.
66, 1581–1587.
Ace, C. I., McKee, T. A., Ryan. M., Cameron, J. M., and Preston, C. M.
Goldstein, D. J., and Weller, S. K. (1988). Factor(s) present in the herpes(1989). Construction and characterization of a herpes simplex virus
simplex virus type-1 infected cells can compensate for the loss of thetype 1 mutant unable to transinduce immediate-early gene expres-
large subunit of the viral ribonucleotide reductase:characterization ofsion. J. Virol. 63, 2260–2269.
an ICP6 deletion mutant. Virology 166, 41–51.Ali, M. A., McWheeney, D., Milosavlievic, A., Jurka, J., and Jariwalla, R.
Hayashi, Y., Iwasaka, T., Smith, C. C., Aurelian, L., Lewis, G. K., and(1991). Enhanced malignant transformation induced by expression
Ts’o, P. O. P. (1985). Multistep transformation by defined fragmentsof a distinct protein domain of ribonucleotide reductase large subunit
of herpes simplex virus type 2 DNA: Oncogenic region and its genefrom herpes simplex virus type 2. Proc. Natl. Acad. Sci. USA 88,
product. Proc. Natl. Acad. Sci. USA 82, 8493–8497.8527–8261.
Heine, J. W., Honess, R. W., Cassai, E., and Roizman, B. (1974) ProteinsAli, M. A. (1995). The 140kDa RR 1 protein from both HSV-1 and HSV-
specified by herpes simplex virus. XIII. The virion polypeptides of2 contains an intrinsic protein kinase activity capable of autophos-
type 1 strains. J. Virol. 14, 640–651.phorylation but it is transphosphorylation defective. Virology 207,
Hunter, J. C. R., Smith, C. C., Bose, D., Kulka, M., Broderick, R., and409–416.
Aurelian, L. (1995). Intracellular internalization and signaling path-Aurelian, L., Terzano, P., Smith, C. C., Chung, T. C., Shamsuddin, A.,
ways triggered by the large subunit of HSV-2 ribonucleotide reduc-Costa, S., and Orlandi, C. (1989). Amino-terminal epitope of herpes
tase (ICP10). Virology 210, 345–360.simplex virus type 2 ICP10 protein as a molecular diagnostic marker
Huszar, D., Beharry, S., and Bacchetti, S. (1983). Herpes simplex virusfor cervical intraepithelial neoplasia. Cancer Cells 7, 187–191.
induced ribonucleotide reductase: Development of antibodies spe-Bacchetti, S., Evelegh, M. J., Miurhead, B., Dartari, C. S., and Huszar,
cific for the enzyme. J. Gen. Virol. 64, 1327–1335.D. (1984). Immunological characterization of herpes simplex virus
Ingemarson, R., and Lankinen, H. (1987). The herpes simplex virustype 1 and 2 polypeptide(s) involved in ribonucleotide reductase
activity. J. Virol. 49, 591–593. type 1 ribonucleotide reductase is a tight complex of the type a2b2
AID VY 8645 / 6a3d$$$121 07-08-97 13:18:51 vira AP: VY
242 SMITH AND AURELIAN
composed of a 40k and 140k proteins, of which the latter shows (1995). Labeling of surface proteins of herpes simplex virus type 1
using a modified biotin-streptavidin system. Virus Res. 37, 253–270.multiple forms due to proteolysis. Virology 156, 417–422.
Smibert, C. A., Johnson, D. C., and Smiley, J. R. (1992). Identification andJariwalla, R. J., Aurelian, L., and Ts’o, P. O. P. (1980). Tumorigenic trans-
characterization of the virion-induced host shut-off product of herpesformation induced by a specific fragment of DNA from herpes simplex
simplex virus gene UL41. J. Gen. Virol. 73, 467–470.virus type 2. Proc. Natl. Acad. Sci. USA 77, 2279–2283.
Smith, C. C., Luo, J. H., Hunter, J. C. R., Ordonez, J. V., and Aurelian, L.Kwong, A. D., Kruper, J. A., and Frenkel, N. (1988). Herpes simplex virus
(1994). The transmembrane domain of the large subunit of HSV-2virion host shutoff function. J. Virol. 62, 912–921.
ribonucleotide reductase (ICP10) is required for the transformation-
Lemaster, S., and Roizman, B. (1980). Herpes simplex virus phospho-
related signaling pathways that involve ras activation. Virology 200,
proteins. II. Characterization of the virion protein kinase and of the 598–612.
polypeptides phosphorylated in the virion. J. Virol. 35, 798–811. Smith, C. C., Kulka, M., Wymer J. P., Chung, T. D., and Aurelian, L. (1992).
Luo J., Smith, C. C., Kulka, M., and Aurelian, L. (1991). A truncated Expression of the large subunit of herpes simplex virus type 2 ribonu-
protein kinase domain of the large subunit of herpes simplex virus cleotide reductase (ICP10) is required for virus growth and neoplastic
type 2 ribonucleotide reductase (ICP10) expressed in Esherichia coli. transformation. J. Gen. Virol. 73, 1417–1428.
J. Biol. Chem. 266, 20976–20983. Smith, C. C., Peng, T., Kulka, M., and Aurelian, L. The PK Domain of the
Luo, J., and Aurelian, L. (1992). The transmembrane helical segment large subunit of herpes simplex virus type 2 ribonucleotide reductase
but not the invariant lysine is required for the kinase activity of the (ICP10) is involved in IE gene transcription and virus growth. Submit-
ted.large subunit of herpes simplex virus type 2 ribonucleotide reductase
Strnad, B. C., and Aurelian, L. (1976). Proteins of herpesvirus type 2. I.(ICP10). J. Biol. Chem. 267, 9645–9653.
Virion, nonvirion, and antigenic polypeptides in infected cells. Virol-McNabb, D. S., and Courtney, R. J. (1992). Analysis of the UL36 open
ogy 69, 438–452.reading frame encoding the large tegument protein (ICP1/2) of her-
Strnad, B. C., and Aurelian, L. (1978). Proteins of herpesvirus type 2.pes simplex virus type 1. J. Virol. 66, 7581–7584.
III. Isolation and immunologic characterization of a large molecularMorrison, M. (1974). The determination of the exposed proteins on
weight viral protein. Virology 87, 401–415.membranes by the use of lactoper oxidase. In ‘‘Methods in Enzymol-
Szilagyi, J. F., and Cunningham, C. (1991). Identification and character-ogy’’ (S. Fleischer and L. Packer, Eds.), Vol. 32, pp. 103–109. Aca-
ization of a novel non-infectious herpes simplex virus-related particle.demic Press, New York.
J. Gen. Virol. 72, 661–668.
Nelson, J. W., Zhu, J., Smith, C. C., Kulka, M., and Aurelian, L. (1996). Weinheimer, S. P., Boyd, B. A., Durham, S. K., Resnick, J. L., and O’Boyle
ATP and SH 3 binding sites in the protein kinase of the large subunit II, D. R. (1992). Deletion of the VP16 open reading frame of herpes
of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J. simplex virus type 1. J. Virol. 66, 258–269.
Biol. Chem. 271, 17021–17027. Wymer, J. P., Chung, T. D., Chang, Y. N., Hayward, G. S., and Aurelian,
Overton, H. A., McMillan, D. J., Klavinskis, L. S., Hope, L., Ritchie, A. J., L. (1989). Identification of immediate-early type cis-response ele-
and Wong-Kai-in, P. (1992). Herpes simplex virus type 1 gene UL13 ments in the promoter for the ribonucleotide reductase large subunit
encodes a phosphoprotein that is a component of the virion. Virology from herpes simplex virus type 2. J. Virol. 63, 2773–2784.
190, 184–192. Wymer, J. P., Aprhys, C. M. J., Chung, T. C., Feng, T. P., Kulka, M., and
Aurelian, L. (1992). Immediate early and functional AP-1 cis-responseParadis, H., Gaudreau, P., Massie, B., Lamarche, N., Guilbault, C.,
elements are involved in the transcriptional regulation of the largeGravel, S., and Langelier, Y. (1991). Affinity purification of active sub-
subunit of herpes simplex virus type 2 ribonucleotide reductaseunit 1 of herpes simplex virus type 1 ribonucleotide reductase exhib-
(ICP10). Virus Res. 23, 253–270.iting a protein kinase function. J. Biol. Chem. 266, 9647–9651.
Yao, F., and Courtney, R. J. (1989). A major transcriptional regulatoryPellet, P. E., McKnight, J. L. C., Jenkins, F. J., and Roizman, B. (1985).
protein (ICP4) of herpes simplex virus type 1 is associated withNucleotide sequence and predicted amino acid sequence of a pro-
purified virions. J. Virol. 63, 3338–3344.tein encoded in a small herpes simplex virus DNA fragment capable
Yao, F., and Courtney, R. J. (1992). Association of ICP0 but not ICP27of transinducing a genes. Proc. Natl. Acad Sci. USA 82, 5870–5874.
with purified virions of herpes simplex virus type 1. J. Virol. 66, 2709–
Peng, T., Hunter, J. R. C., and Nelson, J. W. (1996). The novel protein
2716.
kinase of the RR1 subunit of herpes simplex virus has autophosphor-
Zhang, G., Stevens, R., and Leader, D. P. (1990). The protein kinase
ylation and transphosphorylation activity that differs in its ATP re- encoded in the short unique region of pseudorabies virus: Descrip-
quirements for HSV-1 and HSV-2. Virology 216, 184–196. tion of the gene and identification of its product in virions and in
Preston, V. G., Palfreyman, J. W., and Dutia, B. M. (1984). Identification infected cells. J. Gen. Virol. 71, 1757–1765.
of a herpes simplex virus type 1 polypeptide which is a component Zhu, Y., and Aurelian, L. (1997). AP-1 cis-response elements are in-
of the virus-induced ribonucleotide reductase. J. Gen. Virol. 65, 1457– volved in basal expression and Vmw110 transactivation of the large
1466. subunit of herpes simplex virus type 2 ribonucleotide reductase
(ICP10). Virology 231, 301–312.Skulstad, S., Rodahl, E., Jakobsen, K., Langeland, N., and Haarr, L.
AID VY 8645 / 6a3d$$$121 07-08-97 13:18:51 vira AP: VY
